Aaron Mercer, based in Shoreline, Washington, United States, is currently a Senior Principal Scientist - External Innovation, Cardiometabolic Diseases Research at Boehringer Ingelheim, bringing experience from previous roles at Novo Nordisk and University of Michigan. Aaron Mercer holds a 2011 - 2015 Postdoctoral Fellowship in Molecular & Integrative Physiology @ University of Michigan. With a robust skill set that includes Immunohistochemistry, Molecular Biology, Confocal Microscopy, Neuroscience, Fluorescence Microscopy and more, Aaron Mercer contributes valuable insights to the industry. Aaron Mercer has 3 emails on RocketReach.